Boryung Pharm (003850) — Cash Flow Reinvestment Rate
Boryung Pharm (003850) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting ₩6.89 Billion (capex ₩4.92 Billion plus investments ₩-1.97 Billion) from operating cash flow of ₩48.95 Billion. See 003850 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Boryung Pharm Cash Flow Reinvestment Rate (2009–2024)
Historical reinvestment intensity for Boryung Pharm across 12 annual periods. For the full cash flow conversion analysis, see 003850 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Boryung Pharm (2009–2024)
Year-by-year capital reinvestment analysis for Boryung Pharm. See Boryung Pharm (003850) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | ₩21.02 Billion | ₩80.56 Billion | ₩20.05 Billion | ▼ -79.0% |
| 2023 | 1.24x | ₩52.51 Billion | ₩42.22 Billion | ₩23.35 Billion | ▼ -49.9% |
| 2022 | 2.48x | ₩69.06 Billion | ₩27.81 Billion | ₩20.28 Billion | ▲ +329.3% |
| 2021 | 0.58x | ₩34.80 Billion | ₩60.17 Billion | ₩16.13 Billion | ▼ -70.4% |
| 2020 | 1.95x | ₩87.43 Billion | ₩44.74 Billion | ₩18.27 Billion | ▲ +21.7% |
| 2019 | 1.61x | ₩75.50 Billion | ₩47.00 Billion | ₩67.02 Billion | ▲ +14.0% |
| 2018 | 1.41x | ₩54.83 Billion | ₩38.91 Billion | ₩54.83 Billion | ▼ -77.7% |
| 2016 | 6.33x | ₩59.22 Billion | ₩9.36 Billion | ₩26.83 Billion | ▲ +1065.3% |
| 2012 | 0.54x | ₩9.98 Billion | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩14.17 Billion | ₩9.19 Billion | ₩14.16 Billion | ▲ +23.6% |
| 2010 | 1.25x | ₩30.08 Billion | ₩24.12 Billion | ₩29.77 Billion | ▼ -61.5% |
| 2009 | 3.24x | ₩11.64 Billion | ₩3.59 Billion | ₩11.28 Billion | — |